Approximately one in four patients died, deteriorated to a higher shock stage, or were transferred for a higher level of care ...

The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).

The findings underscore the need to treat heart failure with urgency and double down on clinician education, one expert says.